Global EGFR Inhibitor Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 100

Published Date: 08 Jun 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global EGFR Inhibitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global EGFR Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global EGFR Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global EGFR Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global EGFR Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global EGFR Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for EGFR Inhibitor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global EGFR Inhibitor market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Roche, Boehringer-Ingelheim, Pfizer and Mylan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
EGFR Inhibitor market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    First Generation
    Second Generation
    Three Generations
    Four Generations

Market segment by Application
    Healthcare
    Experimental Use
    Other

Major players covered
    AstraZeneca
    Roche
    Boehringer-Ingelheim
    Pfizer
    Mylan
    Genvio Pharma
    Alice
    Teva Pharmaceuticals
    Blueprint Medicines
    Biotherapeutics
    Junshi Biosciences
    Cttq
    Betta Pharmaceuticals
    Qilu Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe EGFR Inhibitor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of EGFR Inhibitor, with price, sales, revenue and global market share of EGFR Inhibitor from 2018 to 2023.
Chapter 3, the EGFR Inhibitor competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EGFR Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and EGFR Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of EGFR Inhibitor.
Chapter 14 and 15, to describe EGFR Inhibitor sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of EGFR Inhibitor
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global EGFR Inhibitor Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 First Generation
        1.3.3 Second Generation
        1.3.4 Three Generations
        1.3.5 Four Generations
    1.4 Market Analysis by Application
        1.4.1 Overview: Global EGFR Inhibitor Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Healthcare
        1.4.3 Experimental Use
        1.4.4 Other
    1.5 Global EGFR Inhibitor Market Size & Forecast
        1.5.1 Global EGFR Inhibitor Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global EGFR Inhibitor Sales Quantity (2018-2029)
        1.5.3 Global EGFR Inhibitor Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca EGFR Inhibitor Product and Services
        2.1.4 AstraZeneca EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AstraZeneca Recent Developments/Updates
    2.2 Roche
        2.2.1 Roche Details
        2.2.2 Roche Major Business
        2.2.3 Roche EGFR Inhibitor Product and Services
        2.2.4 Roche EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Roche Recent Developments/Updates
    2.3 Boehringer-Ingelheim
        2.3.1 Boehringer-Ingelheim Details
        2.3.2 Boehringer-Ingelheim Major Business
        2.3.3 Boehringer-Ingelheim EGFR Inhibitor Product and Services
        2.3.4 Boehringer-Ingelheim EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Boehringer-Ingelheim Recent Developments/Updates
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer EGFR Inhibitor Product and Services
        2.4.4 Pfizer EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Pfizer Recent Developments/Updates
    2.5 Mylan
        2.5.1 Mylan Details
        2.5.2 Mylan Major Business
        2.5.3 Mylan EGFR Inhibitor Product and Services
        2.5.4 Mylan EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Mylan Recent Developments/Updates
    2.6 Genvio Pharma
        2.6.1 Genvio Pharma Details
        2.6.2 Genvio Pharma Major Business
        2.6.3 Genvio Pharma EGFR Inhibitor Product and Services
        2.6.4 Genvio Pharma EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Genvio Pharma Recent Developments/Updates
    2.7 Alice
        2.7.1 Alice Details
        2.7.2 Alice Major Business
        2.7.3 Alice EGFR Inhibitor Product and Services
        2.7.4 Alice EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Alice Recent Developments/Updates
    2.8 Teva Pharmaceuticals
        2.8.1 Teva Pharmaceuticals Details
        2.8.2 Teva Pharmaceuticals Major Business
        2.8.3 Teva Pharmaceuticals EGFR Inhibitor Product and Services
        2.8.4 Teva Pharmaceuticals EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Teva Pharmaceuticals Recent Developments/Updates
    2.9 Blueprint Medicines
        2.9.1 Blueprint Medicines Details
        2.9.2 Blueprint Medicines Major Business
        2.9.3 Blueprint Medicines EGFR Inhibitor Product and Services
        2.9.4 Blueprint Medicines EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Blueprint Medicines Recent Developments/Updates
    2.10 Biotherapeutics
        2.10.1 Biotherapeutics Details
        2.10.2 Biotherapeutics Major Business
        2.10.3 Biotherapeutics EGFR Inhibitor Product and Services
        2.10.4 Biotherapeutics EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Biotherapeutics Recent Developments/Updates
    2.11 Junshi Biosciences
        2.11.1 Junshi Biosciences Details
        2.11.2 Junshi Biosciences Major Business
        2.11.3 Junshi Biosciences EGFR Inhibitor Product and Services
        2.11.4 Junshi Biosciences EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Junshi Biosciences Recent Developments/Updates
    2.12 Cttq
        2.12.1 Cttq Details
        2.12.2 Cttq Major Business
        2.12.3 Cttq EGFR Inhibitor Product and Services
        2.12.4 Cttq EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Cttq Recent Developments/Updates
    2.13 Betta Pharmaceuticals
        2.13.1 Betta Pharmaceuticals Details
        2.13.2 Betta Pharmaceuticals Major Business
        2.13.3 Betta Pharmaceuticals EGFR Inhibitor Product and Services
        2.13.4 Betta Pharmaceuticals EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Betta Pharmaceuticals Recent Developments/Updates
    2.14 Qilu Pharmaceutical
        2.14.1 Qilu Pharmaceutical Details
        2.14.2 Qilu Pharmaceutical Major Business
        2.14.3 Qilu Pharmaceutical EGFR Inhibitor Product and Services
        2.14.4 Qilu Pharmaceutical EGFR Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: EGFR Inhibitor by Manufacturer
    3.1 Global EGFR Inhibitor Sales Quantity by Manufacturer (2018-2023)
    3.2 Global EGFR Inhibitor Revenue by Manufacturer (2018-2023)
    3.3 Global EGFR Inhibitor Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of EGFR Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 EGFR Inhibitor Manufacturer Market Share in 2022
        3.4.2 Top 6 EGFR Inhibitor Manufacturer Market Share in 2022
    3.5 EGFR Inhibitor Market: Overall Company Footprint Analysis
        3.5.1 EGFR Inhibitor Market: Region Footprint
        3.5.2 EGFR Inhibitor Market: Company Product Type Footprint
        3.5.3 EGFR Inhibitor Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global EGFR Inhibitor Market Size by Region
        4.1.1 Global EGFR Inhibitor Sales Quantity by Region (2018-2029)
        4.1.2 Global EGFR Inhibitor Consumption Value by Region (2018-2029)
        4.1.3 Global EGFR Inhibitor Average Price by Region (2018-2029)
    4.2 North America EGFR Inhibitor Consumption Value (2018-2029)
    4.3 Europe EGFR Inhibitor Consumption Value (2018-2029)
    4.4 Asia-Pacific EGFR Inhibitor Consumption Value (2018-2029)
    4.5 South America EGFR Inhibitor Consumption Value (2018-2029)
    4.6 Middle East and Africa EGFR Inhibitor Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global EGFR Inhibitor Sales Quantity by Type (2018-2029)
    5.2 Global EGFR Inhibitor Consumption Value by Type (2018-2029)
    5.3 Global EGFR Inhibitor Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global EGFR Inhibitor Sales Quantity by Application (2018-2029)
    6.2 Global EGFR Inhibitor Consumption Value by Application (2018-2029)
    6.3 Global EGFR Inhibitor Average Price by Application (2018-2029)

7 North America
    7.1 North America EGFR Inhibitor Sales Quantity by Type (2018-2029)
    7.2 North America EGFR Inhibitor Sales Quantity by Application (2018-2029)
    7.3 North America EGFR Inhibitor Market Size by Country
        7.3.1 North America EGFR Inhibitor Sales Quantity by Country (2018-2029)
        7.3.2 North America EGFR Inhibitor Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe EGFR Inhibitor Sales Quantity by Type (2018-2029)
    8.2 Europe EGFR Inhibitor Sales Quantity by Application (2018-2029)
    8.3 Europe EGFR Inhibitor Market Size by Country
        8.3.1 Europe EGFR Inhibitor Sales Quantity by Country (2018-2029)
        8.3.2 Europe EGFR Inhibitor Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific EGFR Inhibitor Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific EGFR Inhibitor Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific EGFR Inhibitor Market Size by Region
        9.3.1 Asia-Pacific EGFR Inhibitor Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific EGFR Inhibitor Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America EGFR Inhibitor Sales Quantity by Type (2018-2029)
    10.2 South America EGFR Inhibitor Sales Quantity by Application (2018-2029)
    10.3 South America EGFR Inhibitor Market Size by Country
        10.3.1 South America EGFR Inhibitor Sales Quantity by Country (2018-2029)
        10.3.2 South America EGFR Inhibitor Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa EGFR Inhibitor Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa EGFR Inhibitor Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa EGFR Inhibitor Market Size by Country
        11.3.1 Middle East & Africa EGFR Inhibitor Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa EGFR Inhibitor Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 EGFR Inhibitor Market Drivers
    12.2 EGFR Inhibitor Market Restraints
    12.3 EGFR Inhibitor Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of EGFR Inhibitor and Key Manufacturers
    13.2 Manufacturing Costs Percentage of EGFR Inhibitor
    13.3 EGFR Inhibitor Production Process
    13.4 EGFR Inhibitor Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 EGFR Inhibitor Typical Distributors
    14.3 EGFR Inhibitor Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global EGFR Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global EGFR Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 4. AstraZeneca Major Business
    Table 5. AstraZeneca EGFR Inhibitor Product and Services
    Table 6. AstraZeneca EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. AstraZeneca Recent Developments/Updates
    Table 8. Roche Basic Information, Manufacturing Base and Competitors
    Table 9. Roche Major Business
    Table 10. Roche EGFR Inhibitor Product and Services
    Table 11. Roche EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Roche Recent Developments/Updates
    Table 13. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 14. Boehringer-Ingelheim Major Business
    Table 15. Boehringer-Ingelheim EGFR Inhibitor Product and Services
    Table 16. Boehringer-Ingelheim EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Boehringer-Ingelheim Recent Developments/Updates
    Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer EGFR Inhibitor Product and Services
    Table 21. Pfizer EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Pfizer Recent Developments/Updates
    Table 23. Mylan Basic Information, Manufacturing Base and Competitors
    Table 24. Mylan Major Business
    Table 25. Mylan EGFR Inhibitor Product and Services
    Table 26. Mylan EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Mylan Recent Developments/Updates
    Table 28. Genvio Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. Genvio Pharma Major Business
    Table 30. Genvio Pharma EGFR Inhibitor Product and Services
    Table 31. Genvio Pharma EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Genvio Pharma Recent Developments/Updates
    Table 33. Alice Basic Information, Manufacturing Base and Competitors
    Table 34. Alice Major Business
    Table 35. Alice EGFR Inhibitor Product and Services
    Table 36. Alice EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Alice Recent Developments/Updates
    Table 38. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 39. Teva Pharmaceuticals Major Business
    Table 40. Teva Pharmaceuticals EGFR Inhibitor Product and Services
    Table 41. Teva Pharmaceuticals EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Teva Pharmaceuticals Recent Developments/Updates
    Table 43. Blueprint Medicines Basic Information, Manufacturing Base and Competitors
    Table 44. Blueprint Medicines Major Business
    Table 45. Blueprint Medicines EGFR Inhibitor Product and Services
    Table 46. Blueprint Medicines EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Blueprint Medicines Recent Developments/Updates
    Table 48. Biotherapeutics Basic Information, Manufacturing Base and Competitors
    Table 49. Biotherapeutics Major Business
    Table 50. Biotherapeutics EGFR Inhibitor Product and Services
    Table 51. Biotherapeutics EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Biotherapeutics Recent Developments/Updates
    Table 53. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
    Table 54. Junshi Biosciences Major Business
    Table 55. Junshi Biosciences EGFR Inhibitor Product and Services
    Table 56. Junshi Biosciences EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Junshi Biosciences Recent Developments/Updates
    Table 58. Cttq Basic Information, Manufacturing Base and Competitors
    Table 59. Cttq Major Business
    Table 60. Cttq EGFR Inhibitor Product and Services
    Table 61. Cttq EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Cttq Recent Developments/Updates
    Table 63. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 64. Betta Pharmaceuticals Major Business
    Table 65. Betta Pharmaceuticals EGFR Inhibitor Product and Services
    Table 66. Betta Pharmaceuticals EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Betta Pharmaceuticals Recent Developments/Updates
    Table 68. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 69. Qilu Pharmaceutical Major Business
    Table 70. Qilu Pharmaceutical EGFR Inhibitor Product and Services
    Table 71. Qilu Pharmaceutical EGFR Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Qilu Pharmaceutical Recent Developments/Updates
    Table 73. Global EGFR Inhibitor Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 74. Global EGFR Inhibitor Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 75. Global EGFR Inhibitor Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 76. Market Position of Manufacturers in EGFR Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 77. Head Office and EGFR Inhibitor Production Site of Key Manufacturer
    Table 78. EGFR Inhibitor Market: Company Product Type Footprint
    Table 79. EGFR Inhibitor Market: Company Product Application Footprint
    Table 80. EGFR Inhibitor New Market Entrants and Barriers to Market Entry
    Table 81. EGFR Inhibitor Mergers, Acquisition, Agreements, and Collaborations
    Table 82. Global EGFR Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
    Table 83. Global EGFR Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
    Table 84. Global EGFR Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
    Table 85. Global EGFR Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
    Table 86. Global EGFR Inhibitor Average Price by Region (2018-2023) & (US$/Unit)
    Table 87. Global EGFR Inhibitor Average Price by Region (2024-2029) & (US$/Unit)
    Table 88. Global EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Global EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Global EGFR Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Global EGFR Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Global EGFR Inhibitor Average Price by Type (2018-2023) & (US$/Unit)
    Table 93. Global EGFR Inhibitor Average Price by Type (2024-2029) & (US$/Unit)
    Table 94. Global EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Global EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Global EGFR Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. Global EGFR Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. Global EGFR Inhibitor Average Price by Application (2018-2023) & (US$/Unit)
    Table 99. Global EGFR Inhibitor Average Price by Application (2024-2029) & (US$/Unit)
    Table 100. North America EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 101. North America EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 102. North America EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 103. North America EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 104. North America EGFR Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
    Table 105. North America EGFR Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
    Table 106. North America EGFR Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. North America EGFR Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Europe EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 109. Europe EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 110. Europe EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 111. Europe EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 112. Europe EGFR Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
    Table 113. Europe EGFR Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
    Table 114. Europe EGFR Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe EGFR Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 117. Asia-Pacific EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 118. Asia-Pacific EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 119. Asia-Pacific EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 120. Asia-Pacific EGFR Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
    Table 121. Asia-Pacific EGFR Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
    Table 122. Asia-Pacific EGFR Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
    Table 123. Asia-Pacific EGFR Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
    Table 124. South America EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 125. South America EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 126. South America EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 127. South America EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 128. South America EGFR Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
    Table 129. South America EGFR Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
    Table 130. South America EGFR Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 131. South America EGFR Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 132. Middle East & Africa EGFR Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
    Table 133. Middle East & Africa EGFR Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
    Table 134. Middle East & Africa EGFR Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
    Table 135. Middle East & Africa EGFR Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
    Table 136. Middle East & Africa EGFR Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
    Table 137. Middle East & Africa EGFR Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
    Table 138. Middle East & Africa EGFR Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
    Table 139. Middle East & Africa EGFR Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
    Table 140. EGFR Inhibitor Raw Material
    Table 141. Key Manufacturers of EGFR Inhibitor Raw Materials
    Table 142. EGFR Inhibitor Typical Distributors
    Table 143. EGFR Inhibitor Typical Customers
List of Figures
    Figure 1. EGFR Inhibitor Picture
    Figure 2. Global EGFR Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global EGFR Inhibitor Consumption Value Market Share by Type in 2022
    Figure 4. First Generation Examples
    Figure 5. Second Generation Examples
    Figure 6. Three Generations Examples
    Figure 7. Four Generations Examples
    Figure 8. Global EGFR Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global EGFR Inhibitor Consumption Value Market Share by Application in 2022
    Figure 10. Healthcare Examples
    Figure 11. Experimental Use Examples
    Figure 12. Other Examples
    Figure 13. Global EGFR Inhibitor Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global EGFR Inhibitor Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global EGFR Inhibitor Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global EGFR Inhibitor Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global EGFR Inhibitor Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global EGFR Inhibitor Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of EGFR Inhibitor by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 EGFR Inhibitor Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 EGFR Inhibitor Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global EGFR Inhibitor Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global EGFR Inhibitor Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America EGFR Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe EGFR Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific EGFR Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America EGFR Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa EGFR Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global EGFR Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global EGFR Inhibitor Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global EGFR Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global EGFR Inhibitor Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America EGFR Inhibitor Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America EGFR Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe EGFR Inhibitor Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe EGFR Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific EGFR Inhibitor Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific EGFR Inhibitor Consumption Value Market Share by Region (2018-2029)
    Figure 55. China EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America EGFR Inhibitor Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America EGFR Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa EGFR Inhibitor Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa EGFR Inhibitor Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa EGFR Inhibitor Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa EGFR Inhibitor Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa EGFR Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. EGFR Inhibitor Market Drivers
    Figure 76. EGFR Inhibitor Market Restraints
    Figure 77. EGFR Inhibitor Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of EGFR Inhibitor in 2022
    Figure 80. Manufacturing Process Analysis of EGFR Inhibitor
    Figure 81. EGFR Inhibitor Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Roche
Boehringer-Ingelheim
Pfizer
Mylan
Genvio Pharma
Alice
Teva Pharmaceuticals
Blueprint Medicines
Biotherapeutics
Junshi Biosciences
Cttq
Betta Pharmaceuticals
Qilu Pharmaceutical

Related Reports

Global EGFR Inhibitor Supply, Demand and Key Producers, 2023-2029

Global EGFR Inhibitor Supply, Demand and Key Producers, 2023-2029

date 08 Jun 2023

date Pharma & Healthcare

The global EGFR Inhibitor market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global EGFR Inhibitor Supply, Demand and Key Producers, 2024-2030

Global EGFR Inhibitor Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global EGFR Inhibitor market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

epidermal factor receptor egfr inhibitor

Epidermal Growth Factor Receptor (EGFR) Inhibitor

EGFR Inhibitor

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>